Chfr is linked to tumour metastasis through the downregulation of HDAC1

Nature Cell Biology

Volumn 11, Issue 3, 2009, Pages 295-302

  Oh, Young Mi ^a   Kwon, Young Eun ^a   Kim, Joo Mi ^a   Bae, S J Sung Jun ^a   Lee, Bo Keun ^a   Yoo, Soon Ji ^b   Chung, Chin Ha ^a   Deshaies, Raymond J ^c   Seol, Jae Hong ^a  

^a Seoul National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; HISTONE DEACETYLASE 1; POLYUBIQUITIN; PROTEIN CHFR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UBIQUITINATION; UPREGULATION;

AMINO ACID SEQUENCE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROTEIN BINDING; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 61849153478     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1837     Document Type: Article

References (25)

1. Kang, D., Chen, J., Wong, J. & Fang, G. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. J. Cell Biol. 156, 249-259 (2002).
2. Yu, X. et al. Chfr is required for tumor suppression and Aurora A regulation. Nature Genet. 37, 401-406 (2005).
3. Scolnick, D. M. & Halazonetis, T. D. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 406, 430-435 (2000).
4. Bothos, J., Summers, M. K., Venere, M., Scolnick, D. M. & Halazonetis, T. D. The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys 63-linked polyubiquitin chains. Oncogene 22, 7101-7107 (2003).
5. Chaturvedi, P. et al. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Cancer Res. 62, 1797-1801 (2002).
6. Oh, Y. M., Yoo, S. J. & Seol, J. H. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity. Biochem. Biophys. Res. Commun. 357, 615-619 (2007).
7. Matsusaka, T. & Pines, J. Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells. J. Cell Biol. 166, 507-516 (2004).
8. Thiagalingam, S. et al. Histone deacetylases: Unique players in shaping the epigenetic histone code. Ann. NY Acad. Sci. 983, 84-100 (2003).
9. Tsai, M. D. FHA: A signal transduction domain with diverse specificity and function. Structure 10, 887-888 (2002).
10. Stavridi, E. S. et al. Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate. Structure 10, 891-899 (2002).
11. Wang, A. G. et al. Histone deacetylase 1 contributes to cell cycle and apoptosis. Biol. Pharm. Bull. 28, 1966-1970 (2005).
12. Kim, J. H. et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434 921-926 (2005).
13. David, G., Neptune, M. A. & DePinho, R. A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277, 23658-23663 (2002).
14. Ito, A. et al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21, 6236-6245 (2002).
15. Ocker, M. & Schneider-Stock, R. Histone deacetylase inhibitors: signalling towards p21cip1/waf1. Int. J. Biochem. Cell Biol. 39 1367-1374 (2007).
16. Li, H. & Wu, X. Histone deacetylase inhibitor, trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-Myc and release of the repression of c-Myc from the promoter in human cervical cancer cells. Biochem. Biophys. Res. Commun. 324, 860-867 (2004).
17. Senese, S. et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol. Cell. Biol. 27, 4784-4795 (2007).
18. Mizuno, K. et al. Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene 21, 2328-2333 (2002).
19. Brandes, J. C., van Engeland, M., Wouters, K. A., Weijenberg, M. P. & Herman, J. G. CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype. Carcinogenesis 26, 1152-1156 (2005).
20. Privette, L. M., Gonzalez, M. E., Ding, L., Kleer, C. G. & Petty, E. M. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: Implications for tumor suppression. Cancer Res. 67, 6064-6074 (2007).
21. Cheng, C. W. et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene. Oncogene 20, 3814-3823 (2001).
22. Yang, J. Y. et al. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol. Cell. Biol. 26, 7269-7282 (2006).
23. Kim, J. H. et al. Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nature Cell Biol. 8, 631-639 (2006).
24. Baker, D. J., Chen, J. & van Deursen, J. M. The mitotic checkpoint in cancer and aging: What have mice taught us? Curr. Opin. Cell Biol. 17, 583-589 (2005).
25. Cao, R., Tsukada, Y. & Zhang, Y. Role of Bmi-1 and Ring21A in H2A ubiquitylation and Hox gene silencing. Mol. Cell 20, 845-854 (2005).